University of Kentucky Markey Cancer Center | Strategic Alliance Partners
Latest from University of Kentucky Markey Cancer Center
Holly Chitwood, DNP, APRN, FNP-C, AGACNP-BC, shares her real-world experience with circulating-tumor-DNA monitoring in the colorectal cancer setting.
Holly Chitwood, DNP, FNP-C, AGACNP-BC, explains how circulating tumor DNA monitoring helps providers screen minimal residual disease in individuals with colorectal cancer.
To evaluate the prevalence of financial toxicity and observe the effect of Coverage and Cost-of-Care Links, a program providing financial navigation, investigators initiated a nonrandomized study.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Greenlights Niraparib/Abiraterone Acetate With Prednisone in mHSPC
2
Teclistamab/Daratumumab Increases OS, PFS in R/R Multiple Myeloma
3
Pembrolizumab Plus RT Ups T-Cell Infiltration in Early Breast Cancer
4
Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML
5
